FDA Drug Application (079003) for IBANDRONATE SODIUM by WATSON LABS INC

Back to FDA Applications sponsored by WATSON LABS INC

Application Number079003
Product Number001
FormTABLET;ORAL
DosageEQ 150MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameIBANDRONATE SODIUM
Active IngredientIBANDRONATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient IBANDRONATE SODIUM2


Back to FDA Applications sponsored by WATSON LABS INC